About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prospective Evaluation of iCam-OCT

NCT07839923·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Siloam Vision

With

Oregon Health and Science University
Children's Hospital Colorado

Age

0–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

A birth weight of \<1500g, or a gestational age of ≤30 weeks; or
A birth weight between 1500-2000g, or
A gestational age of \>30 weeks, in infants who are believed to be at risk by their attending pediatrician or neonatologist.

You may not be if

Inability to obtain informed consent from the parent or guardian or
The infant is deemed clinically unstable for research imaging by the neonatology team.

The record

StatusCompleted

PhaseNo phase

Taking part68

StartedJan 2026

UpdatedSep 24, 2026

Conditions

Retinopathy of Prematurity

Where1

OHSU
Portland, Oregon, United States

Clareo Health | Prospective Evaluation of iCam-OCT